Prostate Cancer Clinical Trials in Miami, FL

Prostate Cancer Clinical Trials in Miami, FL

View the best 10 prostate cancer medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Prostate Cancer clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for prostate cancer in Miami, Florida

Image of Exelixis Clinical Site #4 in Tucson, United States.

Atezolizumab +1 More

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the safety and efficacy of cabozantinib in combination with atezolizumab versus a second novel hormonal therapy in men with mCRPC.
Image of Nebraska Cancer Specialists in Omaha, United States.

177Lu-PSMA-617 +2 More

Radioisotope Therapy

Recruiting2 awardsPhase 3
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Image of The Stamford Hospital in Stamford, United States.

Relugolix

Gonadotropin-Releasing Hormone (GnRH) Antagonist

Recruiting1 award
"This trial aims to gather real-world information on how safe and effective ORGOVYX is for patients with prostate cancer in regular clinical settings. It will also look at how patients respond to treatment with
Image of Blue Ridge Cancer Care ( Site 0004) in Roanoke, United States.

Enzalutamide +2 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is studying a new drug called MK-5684 for men with advanced prostate cancer who have already received certain treatments. The study will compare MK-5684 to other drugs currently used in this
Image of NCT02531516 in Homewood, United States.

Apalutamide +3 More

Androgen Receptor Inhibitor

Recruiting1 awardPhase 3
This trial tests whether combining apalutamide with another treatment helps men with high-risk prostate cancer undergoing radiation therapy. The treatment aims to block and reduce male hormones that fuel cancer growth, potentially preventing the cancer from spreading. Apalutamide has been developed for treating prostate cancer and has shown effectiveness.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Rucaparib camsylate +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial is testing if a combination of two drugs, rucaparib and enzalutamide, is better than enzalutamide alone for treating men with prostate cancer that has spread and become resistant to testosterone-deprivation therapy.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Nivolumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a possible treatment for rare genitourinary tumors.
Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Androgen Deprivation Therapy (ADT) +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial is testing if using apalutamide and hormone therapy around the time of surgery can help men with high-risk prostate cancer by reducing the hormones that help the cancer grow.
Image of Arizona Institute of Urology, PPLC in Tucson, United States.

177Lu-PSMA-I&T +1 More

Radioisotope Therapy

Recruiting2 awardsPhase 3
This trial is testing a new radioactive drug against standard hormone therapy in men with advanced prostate cancer that doesn't respond to usual treatments. The drug targets and kills cancer cells using radiation. The drug being tested, 225Ac-PSMA-617, has shown promise in inducing complete responses in patients with metastatic castrate-resistant prostate cancer who were resistant to standard therapies.
Image of Urology Specialist Group in Hialeah, United States.

TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)

Procedure

Recruiting1 award9 criteria
This trial tests a new laser treatment for men aged 50-80 with certain types of prostate cancer. The laser heats and destroys cancer cells, guided by advanced imaging to protect healthy tissue. The goal is to reduce side effects like impotence and incontinence seen with traditional treatments. Recently, there has been an increase in research and development of targeted prostate cancer treatments due to the high number of localized prostate cancers.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.